Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical ...

Diseases marked by progressive deterioration of the brain—neurodegeneration—have proven challenging to understand and treat.

Metabolic dysfunctions are one of the major contributors to the development of Alzheimer’s Disease (AD). They are one of the main causes of the inflammatory ...

UiB researchers are behind a new discovery that tells us how associated neurodegenerative diseases might develop. In the centre of this new ...

Tiziana Life Sciences develops foralumab for treating neurodegenerative diseases like SPMS and Alzheimer's, with promising ...

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer's disease has been licenced to ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

A novel brain mapping method reveals complex neural interactions, enabling task identification, unique brain “fingerprints,” ...

They grew their organoids in a lab using human induced pluripotent stem cells from healthy donors and patients with MS and Parkinson's disease. These are stem cells that are created by taking normal ...

End-of-life health care service use differed between decedents with neurodegenerative diseases and those with pancreatic or brain cancer.

The full spectrum of gene expression regulation associated with many neurodegenerative diseases, including Alzheimer’s, is ...

Deubiquitinases (DUBs) are enzymes used by cells to trim protein modifications made from the protein ubiquitin, and thereby regulate proteins. Malfunctioning of DUBs could lead to diseases, including ...